Pulsed Lavage in Implant-Based Breast Reconstruction

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05585710
Collaborator
(none)
62
1
2
13
4.8

Study Details

Study Description

Brief Summary

To determine if there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction. Primary outcomes will include post-op complications including surgical site infection (SSI), hematoma, seroma, and implant failure.

Condition or Disease Intervention/Treatment Phase
  • Other: Pulsed Lavage Washout
  • Procedure: Implant-based breast reconstruction
  • Procedure: Bilateral or unilateral mastectomy
  • Device: Tissue expander
  • Other: Acellular dermal matrix
N/A

Detailed Description

After being informed of the study including potential risks and benefits, all patients giving consent who meet eligibility requirements will undergo randomization into either the pulsed lavage arm (receive mastectomy pocket wash out using pulsed lavage) or the no pulsed lavage arm (pulsed lavage will not be used). Randomization will occur using a random number generator with even numbers resulting in a pulsed lavage washout and odd numbers resulting in no pulsed lavage washout.

The patients will be followed in clinic for a maximum of 3 months to evaluate the surgical site. The two cohorts will be compared at the end of the study to determine whether there is any benefit to using pulsed lavage to wash out the mastectomy pocket during breast reconstruction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two cohorts will be established. One cohort will include patients who undergo pulsed lavage to wash out the mastectomy pocket. The other cohort will include patients who do not receive pulsed lavage.Two cohorts will be established. One cohort will include patients who undergo pulsed lavage to wash out the mastectomy pocket. The other cohort will include patients who do not receive pulsed lavage.
Masking:
None (Open Label)
Masking Description:
Pulsed Lavage is a surgical technique that cannot be masked from the investigators performing the operation.
Primary Purpose:
Prevention
Official Title:
Pulsed Lavage in Implant-Based Breast Reconstruction: A Randomized Control Trial
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pulsed Lavage Washout

This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement and pulsed lavage washout.

Other: Pulsed Lavage Washout
Use of pressurized, pulsed normal saline to irrigate mastectomy pocket

Procedure: Implant-based breast reconstruction
Standard of care

Procedure: Bilateral or unilateral mastectomy
Standard of care

Device: Tissue expander
Standard of care

Other: Acellular dermal matrix
Standard of care

Active Comparator: No Pulsed Lavage

This cohort will undergo standard of care bilateral or unilateral mastectomies as determined by breast surgical oncologists and immediate standard of care breast reconstruction with tissue expander placement.

Procedure: Implant-based breast reconstruction
Standard of care

Procedure: Bilateral or unilateral mastectomy
Standard of care

Device: Tissue expander
Standard of care

Other: Acellular dermal matrix
Standard of care

Outcome Measures

Primary Outcome Measures

  1. Post-op Complications [up to 3 months]

    unintended complications that occur post-surgically

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female

  • Between 18 and 75 years of age, inclusive

  • Undergoing implant-based breast reconstruction (unilateral or bilateral) with immediate expander at mastectomy

  • Able to understand and willing to sign an Institutional Review Board (IRB) approved written informed consent document

Exclusion Criteria:
  • Male

  • < 18 years of age or > 75 years of age

  • Undergoing implant-based breast reconstruction (unilateral or bilateral) with delayed expander at mastectomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

  • Principal Investigator: Prasanth Patcha, MD, University of Alabama at Birmingham

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prasanth Patcha, Assistant Professor in the Department of Plastic Surgery, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT05585710
Other Study ID Numbers:
  • IRB-300009900
First Posted:
Oct 19, 2022
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prasanth Patcha, Assistant Professor in the Department of Plastic Surgery, University of Alabama at Birmingham

Study Results

No Results Posted as of Jan 26, 2023